ABL’s fill and finish drug manufacturing capabilities meet U.S. FDA and European GMP requirements for a wide variety of live/vectored products at pilot and clinical scales and commercial-ready. Our in Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Asymmetrex introduces the first stem cell-specific quality control test to suppliers at the 6th Annual Clinical Trial Supply New England 2017 in Boston. Read More
CAMBRIDGE, Mass. (December 13, 2016) – Platelet BioGenesis, a biotech startup developing a method for producing life-saving platelets without the need for human donations, is excited to announce that Read More
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced support of the newly... Read More
On Nov. 15, Asymmetrex Director Sherley presented the business vision of the company and published a new positive perspective on private stem cell clinics in the U.S.. Read More
The PAI is a crucial step in bringing a drug to market so it’s critical to assemble the correct team to handle all of the different aspects of these inspections. Without the appropriate strategy a drug can be delayed and... Read More
AllCells, LLC, today announced signing a Clinical Operations lease agreement, and commencing construction of its new collection facility Read More